COS.L Regulatory News (COS)

Collagen Solutions Plc

(the "Company" or the "Group")

Mr Tom Hyland joins Collagen Solutions Scientific Advisory Board.

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, is pleased to welcome Mr Tom Hyland as scientific adviser to the company.

Mr Hyland has a wealth of experience in the field of collagen chemistry and the development, manufacturing, validation and engineering requirements of collagen-based medical devices. He is a recognised expert in the field as a six sigma black belt, and has played a major role in bringing a number of highly successful collagen-based products to market.

Tom has worked with an impressive list of global life science companies, including Johnson and Johnson Wound Management where he was involved in the identification and commercialisation of a series of products which now have global sales exceeding £50m per annum. He was also employed at Microsulis, Intercell, Alere and Invitrogen, in a range of senior operational roles in the areas of Drugs, Diagnostics & Interventional Devices, manufacture scale up and production technology.

Such expertise is now essential as Collagen Solutions starts to develop its own proprietary products, including the technology of Professor Robert Brown at UCL that was recently licensed. Tom will be working closely with Professor Brown and the management team to identify and oversee the manufacture and development of novel collagen-based products for Collagen Solutions to commercialise.

Dr Stewart White, Chief Executive Officer of Collagen Solutions, said: "Tom has over 25 years of identifying and manufacturing collagen devices, diagnostics and biological products which is an ideal profile for us as we capture a greater proportion of the value chain and develop our own range of proprietary collagen products. I am delighted to welcome Tom to our scientific advisory board where he will be able to identify and create the new generation of collagen products that will create shareholder value in this rapidly growing and exciting area of regenerative medicine. Tom's common sense approach, collagen engineering pedigree and operational capabilities will add real value to our business and help accelerate company growth and help deliver our strategy and realise our vision."

Mr Hyland is currently the General Manager of API Foils Europe in Livingston, has a Honours Degree in Chemistry and Chemical Engineering and a MBA from Herriot Watt University.

Enquiries:

Notes to Editors:

Six Sigma

Six Sigma is a business management strategy that was initially developed by Motorola in the 1980's, and now is used in many Fortune 500 companies. It is used primarily to identify and rectify errors and defects in a manufacturing or business process in order to increase efficiencies and output.